Proto Labs (NYSE:PRLB – Get Rating) had its target price decreased by research analysts at Craig Hallum from $56.00 to $50.00 in a research report issued to clients and investors on Monday, The Fly reports. Craig Hallum’s price objective suggests a potential upside of 8.86% from the company’s previous close.
A number of other research analysts have also issued reports on PRLB. StockNews.com began coverage on Proto Labs in a research report on Thursday, March 31st. They set a “hold” rating for the company. Zacks Investment Research upgraded Proto Labs from a “sell” rating to a “hold” rating in a research report on Wednesday, March 2nd. Five investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $54.50.
NYSE:PRLB opened at $45.93 on Monday. Proto Labs has a 12-month low of $41.73 and a 12-month high of $104.99. The firm has a market capitalization of $1.26 billion, a P/E ratio of 36.45 and a beta of 1.43. The business has a 50 day simple moving average of $49.79 and a 200 day simple moving average of $52.72.
Institutional investors have recently made changes to their positions in the company. Antonetti Capital Management LLC lifted its holdings in shares of Proto Labs by 84.5% in the fourth quarter. Antonetti Capital Management LLC now owns 524 shares of the industrial products company’s stock valued at $27,000 after buying an additional 240 shares during the period. Signaturefd LLC raised its position in shares of Proto Labs by 1,680.6% during the fourth quarter. Signaturefd LLC now owns 552 shares of the industrial products company’s stock worth $28,000 after purchasing an additional 521 shares during the period. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Proto Labs during the fourth quarter worth $28,000. Hardy Reed LLC acquired a new stake in shares of Proto Labs during the first quarter worth $30,000. Finally, Concord Wealth Partners raised its position in shares of Proto Labs by 129.3% during the fourth quarter. Concord Wealth Partners now owns 633 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 357 shares during the period. Institutional investors and hedge funds own 93.35% of the company’s stock.
About Proto Labs (Get Rating)
Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.
- Get a free copy of the StockNews.com research report on Proto Labs (PRLB)
- Mattel Stock is Ready to Catch
- Littelfuse Stock is Hitting on All Cylinders
- HCA Healthcare Stock is Ready to Climb Higher
- ChemoCentryx: A Biotech Stock Well Worth the Risk
- Skechers Stock Can Be Bought on Pullbacks
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.